We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Grab These 3 Healthcare Mutual Funds for Remarkable Returns
Read MoreHide Full Article
Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions and thus the sector offers sufficient protection to the capital invested. Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate steady cash flows, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Select Pharmaceuticals Portfolio invests the majority of its net assets in common stocks of companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs. To arrive at their investment decision, FPHAX advisors employ fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions.
Fidelity Select Pharmaceuticals Portfolio has three-year annualized returns of 6.5%. As of November 2024, FPHAX held 51 issues, with 24.7% of its assets invested in Eli Lilly.
Vanguard Health Care Fund invests the majority of its net assets in the common stocks of foreign and domestic companies. These companies are engaged in the development, production, or distribution of products and services related to pharmaceutical and medical supply companies, as well as businesses that operate hospitals and other healthcare facilities.
Vanguard Health Care Fund has three-year annualized returns of 2.2%. VGHCX has an expense ratio of 0.38%.
Fidelity Advisor Biotechnology Fund invests the majority of its net assets in securities of companies principally engaged in the research, development, manufacture and distribution of various biotechnological products, services and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. FBTIX’s investments are mostly based on a fundamental analysis of companies and their market position with respect to broader economic conditions.
Fidelity Advisor Biotechnology Fund has three-year annualized returns of 3.9%. Eirene Kontopoulos has been the fund manager of FBTIX since July 2018.
Image: Bigstock
Grab These 3 Healthcare Mutual Funds for Remarkable Returns
Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions and thus the sector offers sufficient protection to the capital invested. Many pharmaceutical companies also offer regular dividends. Companies that consistently pay out dividends are financially stable and generate steady cash flows, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three top-ranked Healthcare mutual funds, namely Fidelity Select Pharmaceuticals Portfolio (FPHAX - Free Report) , Vanguard Health Care Fund (VGHCX - Free Report) and Fidelity Advisor Biotechnology Fund (FBTIX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Fidelity Select Pharmaceuticals Portfolio invests the majority of its net assets in common stocks of companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs. To arrive at their investment decision, FPHAX advisors employ fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions.
Fidelity Select Pharmaceuticals Portfolio has three-year annualized returns of 6.5%. As of November 2024, FPHAX held 51 issues, with 24.7% of its assets invested in Eli Lilly.
Vanguard Health Care Fund invests the majority of its net assets in the common stocks of foreign and domestic companies. These companies are engaged in the development, production, or distribution of products and services related to pharmaceutical and medical supply companies, as well as businesses that operate hospitals and other healthcare facilities.
Vanguard Health Care Fund has three-year annualized returns of 2.2%. VGHCX has an expense ratio of 0.38%.
Fidelity Advisor Biotechnology Fund invests the majority of its net assets in securities of companies principally engaged in the research, development, manufacture and distribution of various biotechnological products, services and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. FBTIX’s investments are mostly based on a fundamental analysis of companies and their market position with respect to broader economic conditions.
Fidelity Advisor Biotechnology Fund has three-year annualized returns of 3.9%. Eirene Kontopoulos has been the fund manager of FBTIX since July 2018.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>